Industry News
EKF Quo-Test® supports improved medical management of diabetic retinopathy patients
EKF Diagnostics’ Quo-Test® HbA1c analyser is successfully supporting improved medical management of patients with sight-threatening diabetic retinopathy (STDR). The effectiveness of...
Seeking probes and dilators?
New Surgitrac© Instruments single-use lacrimal probes and dilators are available now. Its latest offering includes double-ended Bowmans probes, and punctum dilators in various sizes.
Heidelberg Engineering’s EMR wins tender for 21 hospitals in France
Heidelberg Engineering and its wholly owned subsidiary, Medisoft Limited, have won a high-value contract with AP-HP (Assistance Publique - Hôpitaux de Paris) in France. As a result, the EMR (Electronic Medical Records) product known as...
Glaukos - Transforming glaucoma therapy
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialisation of breakthrough products and procedures designed to transform the treatment of glaucoma, one...
Farmigea Ophthalmics announce a unique lanolin free eye ointment
Farmigea Ophthalmics introduce HydraMed Night Sensitive to their already comprehensive range of dry eye products. This is the only lanolin free eye ointment on the...
Medicel launches first 2-in-1 lens injection system
Medicel, a leading producer of lens injection systems for the medical sector, has launched the world’s first 100% 2-in-1 lens injector, the ACCUJECT DUAL. The new injector enables surgeons to operate either in push or screw mode, allowing more...
Glaukos Videos - iStent Inject
Trabecular bypass surgery with iStent Inject enhances aqueous outflow from the eye , evidence of this is demonstrated through Angiographic visualization of aqueous humor outflow in studies conducted by Dr. Alex Huang M.D, Ph.D
Horus Pharma to distribute intravitreal implant ILUVIEN® in France
Intravitreal implant ILUVIEN, developed by Alimera Sciences, is now available in France, distributor Horus Pharma has announced. ILUVIEN is aimed at patients with vision impairment associated with chronic Diabetic Macular Edema (DME), who have not responded well to other available...
